Greenstone - Top 10 Generic Drug Companies 2010

GreenstoneCompany name: Greenstone
Location: Peapack, NJ
Annual sales (in millions): $1.721
Market share: 5.4%
Head: David Simmons, president, Pfizer's established products business unit

Pharma giant Pfizer has been turning out generics for a while through its Greenstone subsidiary. Pfizer got Greenstone through its April 2003 acquisition of Pharmacia, and the generics unit's operation began to increase the number of drugs it sold last year, when CEO Jeff Kindler formed a business unit headed by David Simmons with its own budget and management focused on products that have lost patent protection, Bloomberg notes. Greenstone manufactures and distributes generic versions of many Pfizer medicines, including several injectables. It also distributes non-Pfizer medicines through agreements with other pharmaceutical companies such as India's Aurobindo.

The established products business unit portfolio contains more than 600 products spanning a wide range of therapeutic areas. Pfizer's global sales of established products are more than $10 billion annually.

While announcing quarterly results earlier this month, Kindler said the company expects new product launches in the EPBU. Products in this unit include Arthrotec, Effexor, Medrol, Norvasc and Relpax.

Greenstone - Top 10 Generic Drug Companies 2010
Read more on

Suggested Articles

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.